Clinical Trial Update: Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101 [Phase 1]

View source ↗

Summary

Long-term follow-up data are being collected for subjects treated with P-BCMA-101 in a Phase 1 study for multiple myeloma. The trial status is Active Not Recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• P-BCMA-101

Snippet

Sponsor: Poseida Therapeutics, Inc. | Conditions: Multiple Myeloma | Phase 1 | Status: ACTIVE_NOT_RECRUITING